Merck and AstraZeneca present final results from Phase 3 PROpel Trial
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
Experts’ conclave to pave holistic approach to cancer management
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
The goal is to bring oncology therapy closer to the communities by integrating all services such as chemotherapy and radiation centers
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
Subscribe To Our Newsletter & Stay Updated